Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics

Levodopa-carbidopa intestinal gel (LCIG, carbidopa-levodopa enteral suspension in the United States) is a treatment option for advanced Parkinson’s disease (PD) patients with motor fluctuations. The objective of this investigation was to identify the baseline characteristics predictive of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Standaert, David G., Boyd, James T., Odin, Per, Robieson, Weining Z., Zamudio, Jorge, Chatamra, Krai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784118/
https://www.ncbi.nlm.nih.gov/pubmed/29387783
http://dx.doi.org/10.1038/s41531-017-0040-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784118/
https://www.ncbi.nlm.nih.gov/pubmed/29387783
http://dx.doi.org/10.1038/s41531-017-0040-2

Ejemplares similares